Immunosuppressants: what the agencies decided
60 molecules in ATC class L04 with a published cross-agency decision record.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| adalimumab | 133 | 11 | Immunosuppressants |
| upadacitinib | 93 | 16 | Immunosuppressants |
| secukinumab | 79 | 12 | Immunosuppressants |
| tocilizumab | 76 | 12 | Immunosuppressants |
| ustekinumab | 71 | 11 | Immunosuppressants |
| infliximab | 69 | 9 | Immunosuppressants |
| lenalidomide | 68 | 13 | Immunosuppressants |
| etanercept | 67 | 8 | Immunosuppressants |
| tofacitinib | 60 | 13 | Immunosuppressants |
| guselkumab | 56 | 13 | Immunosuppressants |
| risankizumab | 56 | 14 | Immunosuppressants |
| bimekizumab | 55 | 14 | Immunosuppressants |
| ravulizumab | 54 | 15 | Immunosuppressants |
| baricitinib | 48 | 14 | Immunosuppressants |
| vedolizumab | 44 | 12 | Immunosuppressants |
| certolizumab pegol | 43 | 11 | Immunosuppressants |
| golimumab | 43 | 10 | Immunosuppressants |
| ixekizumab | 41 | 11 | Immunosuppressants |
| eculizumab | 39 | 11 | Immunosuppressants |
| methotrexate | 38 | 5 | Immunosuppressants |
| abatacept | 34 | 10 | Immunosuppressants |
| tacrolimus | 34 | 8 | Immunosuppressants |
| natalizumab | 33 | 12 | Immunosuppressants |
| canakinumab | 31 | 10 | Immunosuppressants |
| fingolimod | 30 | 12 | Immunosuppressants |
| apremilast | 28 | 10 | Immunosuppressants |
| belimumab | 28 | 12 | Immunosuppressants |
| ocrelizumab | 28 | 12 | Immunosuppressants |
| cladribine | 26 | 12 | Immunosuppressants |
| filgotinib | 26 | 13 | Immunosuppressants |
| sirolimus | 25 | 8 | Immunosuppressants |
| iptacopan | 24 | 12 | Immunosuppressants |
| mirikizumab | 24 | 12 | Immunosuppressants |
| ozanimod | 24 | 12 | Immunosuppressants |
| pomalidomide | 24 | 10 | Immunosuppressants |
| ofatumumab | 22 | 12 | Immunosuppressants |
| efgartigimod alfa | 20 | 11 | Immunosuppressants |
| anakinra | 19 | 7 | Immunosuppressants |
| teriflunomide | 18 | 10 | Immunosuppressants |
| tildrakizumab | 17 | 10 | Immunosuppressants |
| anifrolumab | 16 | 11 | Immunosuppressants |
| avacopan | 16 | 11 | Immunosuppressants |
| sarilumab | 16 | 10 | Immunosuppressants |
| pirfenidone | 15 | 8 | Immunosuppressants |
| spesolimab | 15 | 9 | Immunosuppressants |
| siponimod | 14 | 12 | Immunosuppressants |
| dimethyl | 13 | 8 | Immunosuppressants |
| alemtuzumab | 12 | 8 | Immunosuppressants |
| danicopan | 12 | 11 | Immunosuppressants |
| deucravacitinib | 12 | 10 | Immunosuppressants |
| ritlecitinib | 12 | 10 | Immunosuppressants |
| rozanolixizumab | 12 | 10 | Immunosuppressants |
| zilucoplan | 12 | 11 | Immunosuppressants |
| crovalimab | 11 | 10 | Immunosuppressants |
| inebilizumab | 11 | 10 | Immunosuppressants |
| satralizumab | 11 | 10 | Immunosuppressants |
| brodalumab | 9 | 8 | Immunosuppressants |
| etrasimod | 9 | 9 | Immunosuppressants |
| siltuximab | 8 | 6 | Immunosuppressants |
| thalidomide | 8 | 5 | Immunosuppressants |